drugset / Trial / NCT01561222

Effect of Vitamin D Supplement on Osteoprotegin Expression and Disease Progression in Patients With Chronic Kidney Disease Stage 1 and 2

NCT01561222

Phase 4 Unknown 300 enrolled Taixing People's Hospital
RandomizedParallel-groupDouble-blindPrevention

Summary

Vitamin D Supplement in patients with CKD stage 1 and 2 may change osteoprotegin expression so as to produce beneficial effects of cardiovascular、bone metabolism and CKD progression.

Timeline

Start
2015-07
Primary completion
2016-03
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Calcitriol Small molecule 0.25 ug